University of Missouri, Kansas City
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Missouri, Kansas City sits in the top decile of US sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count).
University of Missouri, Kansas City: 33 sponsored US clinical trials, 4 recruiting.
University of Missouri, Kansas City sponsors 33 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 21 completed. 4 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is COVID-19 Testing Behaviors, with 1 trials.
Top-decile sponsor footprint
University of Missouri, Kansas City ranks in the top decile of sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 26 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
33 total, page 1 of 1
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628
Simultaneous Recumbent Cycling and Cognitive Training
NCT04556227
Group CBT in Parents of Children With Food Allergy
NCT06138431
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
NCT05301413
COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)
NCT07450209
Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial
NCT04680221
Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans
NCT07560969
Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City
NCT06374186
Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders
NCT04725383
Companion Dog Walking for ICU Survivor Health
NCT05820308
A Faithful Response to COVID-19 Project
NCT04978207
A Comparison of Parenting Education Approaches for Adolescent Fathers
NCT03921892
MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women
NCT04104542
Intervention to Reduce Perceived Cognitive Impairment in Multiple Sclerosis
NCT03889327
Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors
NCT03211130
SystemCHANGE™ Intervention on Medication Adherence in Older Adults With Heart Failure
NCT03162848
Horses and Education as Arthritis Therapy
NCT03141853
Comparison of Intra-articular and Intra-tendinous Injections for Treatment of Lateral Epicondylitis
NCT02986646
The Age of OrthoInfo: A Randomized Controlled Trial Evaluating Patient Comprehension of Informed Consent in a Private Practice
NCT02694237
Pain in America: A Randomized Controlled Trial
NCT02710695
Surgeon-Patient Communication: A Randomized Controlled Trial Evaluating the Impact of an Orthopaedic Related Smoking Cessation Discussion After Fracture Surgery
NCT02440529
Timolol Eye Drops in the Treatment of Acute Migraine Headache
NCT02630719
Increasing Adherence to Treatment Recommendations Following a Cardiac Event
NCT02327260
Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection
NCT02046902
Acute Fetal Response to Prenatal Yoga
NCT02063711
Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
NCT02010554
CO-OP Trial: Community-based Outreach on Obesity in Pregnancy
NCT01841424
Development of a Motivational Intervention to Improve Treatment Adherence in MS
NCT01925690
Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy
NCT01239680
Testing Counseling Styles to Motivate Smokers to Quit
NCT01188018
Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS)
NCT00981084
Acetaminophen Versus Ibuprofen for the Control of Immediate and Delayed Pain Following Orthodontic Separator Placement
NCT00484744
Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV
NCT00602758
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 2 |
What is open in the University of Missouri, Kansas City pipeline
4 recruiting of 33 indexed (12% open); 21 completed (64%).
Phase mix: 4 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: COVID-19 Testing Behaviors (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Missouri, Kansas City: open-pipeline peers nationwide
Peers matched on 33 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Missouri, Kansas City sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 33 trials (± recruiting share)
- Aclaris Therapeutics · 33 trials · 3% recruiting
- Antonios Likourezos · 33 trials · 12% recruiting
- Baylor University · 33 trials · 15% recruiting
- Becton, Dickinson and Company · 33 trials · 3% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
- National Institute of Dental and Craniofacial Research (NIDCR) · 12% recruiting · 91 trials
- East Carolina University · 12% recruiting · 58 trials
Related
What to do with this University of Missouri, Kansas City page
33 registered trials is a research-attention snapshot, not an endorsement of University of Missouri, Kansas City or any single study.
- 4 of University of Missouri, Kansas City's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- COVID-19 Testing Behaviors is the condition University of Missouri, Kansas City studies most, compare against other sponsors active in the same condition before evaluating a specific study. See COVID-19 Testing Behaviors trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Missouri, Kansas City pipeline card: 33 registered trials from official public datasets.Report a data error.